Camp4 Therapeutics Corp (CAMP) Institutional Ownership

Ownership Summary

Camp4 Therapeutics Corp (NASDAQ:CAMP) is held by 41 institutional investors per 13F filings through December 2025.

• Collectively, these holders controlled 140.2% of Camp4 Therapeutics's outstanding shares in December 2025, up from 103.4% in September 2025.
• Their total shares held in CAMP increased 38.79% from the prior quarter, while the number of investors in Camp4 Therapeutics increased 7.89% year over year.
• Of these 41 holders, 24 added to their stakes in Camp4 Therapeutics, 10 trimmed positions, and 7 made no changes.
• Institutional investors collectively held 38.25Mn shares in Camp4 Therapeutics as of December 2025, up by 10.69Mn shares quarter on quarter, and up 25.33Mn shares year over year.
• Janus Henderson Group Plc leads ownership in CAMP with 12.62Mn shares as of December 31, 2025, equal to 46.25% of outstanding shares.
• The largest buyers of Camp4 Therapeutics for the quarter ending December 2025 were Janus Henderson Group Plc (6.31Mn), VANGUARD CAPITAL MANAGEMENT LLC (1.53Mn), Stonepine Capital Management, LLC (1.16Mn), SILVERARC CAPITAL MANAGEMENT, LLC (653.59K), SummitTX Capital, L.P. (339.52K).
• The largest sales of CAMP for the quarter ending December 2025 came from Enavate Sciences GP, LLC (844.9K), ADAGE CAPITAL PARTNERS GP, L.L.C. (220.9K), Trails Edge Capital Partners, LP (44.42K), Barclays Plc (38.91K), 683 Capital Management, LLC (18.36K).
• According to Business Quant data, leading holders of CAMP for December 2025 are Janus Henderson Group Plc (12.62Mn), 5AM Venture Management, LLC (5.87Mn), FMR LLC (4.93Mn), Vivo Capital, LLC (4.25Mn), BALYASNY ASSET MANAGEMENT L.P. (2.63Mn), Enavate Sciences GP, LLC (2.19Mn), a16z Capital Management, L.L.C. (2.13Mn), ADAGE CAPITAL PARTNERS GP, L.L.C. (1.96Mn), Trails Edge Capital Partners, LP (1.94Mn), VANGUARD CAPITAL MANAGEMENT LLC (1.53Mn).